SC07-0527 Screening compound: N-[1-(2-cyclohexylacetyl)tetrahydro-1H-pyrrol-3-yl]-N-[2-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)ethyl]acetamide

SC07-0527 Screening compound: N-[1-(2-cyclohexylacetyl)tetrahydro-1H-pyrrol-3-yl]-N-[2-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)ethyl]acetamide
SC07-0527 Screening compound: N-[1-(2-cyclohexylacetyl)tetrahydro-1H-pyrrol-3-yl]-N-[2-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)ethyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound SC07-0527
N-[1-(2-cyclohexylacetyl)tetrahydro-1H-pyrrol-3-yl]-N-[2-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)ethyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

SC07-0527

Molecular Formula

C21H32N4O3 (C21 H32 N4 O3)

Compound Name

N-[1-(2-cyclohexylacetyl)tetrahydro-1H-pyrrol-3-yl]-N-[2-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)ethyl]acetamide

IUPAC name

N-[1-(2-cyclohexylacetyl)pyrrolidin-3-yl]-N-[2-(5-cyclopropyl-124-oxadiazol-3-yl)ethyl]acetamide

SMILES

CC(N(CCc1noc(C2CC2)n1)C(CC1)CN1C(CC1CCCCC1)=O)=O

InChI

InChI=1S/C21H32N4O3/c1-15(26)25(12-10-19-22-21(28-23-19)17-7-8-17)18-9-11-24(14-18)20(27)13-16-5-3-2-4-6-16/h16-18H,2-14H2,1H3/t18-/m1/s1

InChI Key

DGZNRVNCPXPNJX-GOSISDBHSA-N

MDL Number (MFCD)

MFCD32255058

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

388.51

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.138

Distribution Coefficient, logD

3.138

Water Solubility, LogSw

-2.88

Polar Surface Area

65.752

Acid Dissociation Constant (pKa)

24.36

Base Dissociation Constant (pKb)

4.60

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

80.95

SC07-0527 in Drug Discovery

Included in Screening Libraries

GABA Library (7115 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Eye
Targets:
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with SC07-0527 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound SC07-0527?
Check Price and Availability of SC07-0527, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of SC07-0527 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for SC07-0527
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for SC07-0527
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of SC07-0527 available by request